Early advances in a skin cancer vaccine

News » Health

 First advances in skin cancer vaccine

On December 13, Moderna announced positive and encouraging results for a vaccine against melanoma cancer. According to company reports, the vaccine reduced the risk of death or recurrence by 44% compared to standard treatment.

Cancer Melanoma is one of the most common types of cancer. We are often asked to wear sunscreen and beware of prolonged exposure to the sun so as not to get sick from it. The new vaccine works according to the mRAN method, which we remember well from the coronavirus vaccine. This technology actually allows the body to fight specific proteins and train the immune system to attack melanoma cells.

The 157 patients who received 9 doses of the vaccine showed signs of resolution of symptoms and responded well to treatment compared to those who did not receive the vaccine. However, it is important to note that this is a preliminary study and is based on a small group of patients. In addition, each patient's melanoma proteins are slightly different, so the vaccine would have to be produced uniquely for each patient, making it difficult to mass-produce the vaccine.

Follow us on Telegram

Add a Comment

Your email address will not be published. Required fields are marked *